Xue, B.; von Heyking, K.; Gassmann, H.; Poorebrahim, M.; Thiede, M.; Schober, K.; Mautner, J.; Hauer, J.; Ruland, J.; Busch, D.H.;
et al. T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer. Cancers 2022, 14, 5485.
https://doi.org/10.3390/cancers14225485
AMA Style
Xue B, von Heyking K, Gassmann H, Poorebrahim M, Thiede M, Schober K, Mautner J, Hauer J, Ruland J, Busch DH,
et al. T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer. Cancers. 2022; 14(22):5485.
https://doi.org/10.3390/cancers14225485
Chicago/Turabian Style
Xue, Busheng, Kristina von Heyking, Hendrik Gassmann, Mansour Poorebrahim, Melanie Thiede, Kilian Schober, Josef Mautner, Julia Hauer, Jürgen Ruland, Dirk H. Busch,
and et al. 2022. "T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer" Cancers 14, no. 22: 5485.
https://doi.org/10.3390/cancers14225485
APA Style
Xue, B., von Heyking, K., Gassmann, H., Poorebrahim, M., Thiede, M., Schober, K., Mautner, J., Hauer, J., Ruland, J., Busch, D. H., Thiel, U., & Burdach, S. E. G.
(2022). T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer. Cancers, 14(22), 5485.
https://doi.org/10.3390/cancers14225485